Cohort Profile: Burden of Obstructive Lung Disease (BOLD) study

Andre F.S. Amaral; James Potts; Ben Knox-Brown; Emmanouil Bagkeris; Imed Harrabi; Hamid Hacene Cherkaski; Dhiraj Agarwal; Sanjay Juvekar; Mahesh Padukudru Anand; Thorarinn Gislason; Asaad Ahmed Nafees; Kevin Mortimer; Christer Janson; Li Cher Loh; Stefanni Nonna Paraguas; Meriam Denguezli; Mohammed Al Ghobain; David Mannino; Martin Njoroge; Graham Devereux; Terence Seemungal; Cristina Barbara; Ali Kocabaş; Rana Ahmed; Althea Aquart-Stewart; Michael Studnicka; Tobias Welte; Wan C. Tan; Richard N. Van Zyl-Smit; Parvaiz Koul; Vanessa Garcia-Larsen; Cosetta Minelli; A. Sonia Buist; Peter Burney

doi:10.1093/ije/dyad146

Cohort Profile: Burden of Obstructive Lung Disease (BOLD) study

Andre F.S. Amaral, James Potts, Ben Knox-Brown, Emmanouil Bagkeris, Imed Harrabi, Hamid Hacene Cherkaski, Dhiraj Agarwal, Sanjay Juvekar, Mahesh Padukudru Anand, Thorarinn Gislason, Asaad Ahmed Nafees, Kevin Mortimer, Christer Janson, Li Cher Loh, Stefanni Nonna Paraguas, Meriam Denguezli, Mohammed Al Ghobain, David Mannino, Martin Njoroge, Graham DevereuxTerence Seemungal, Cristina Barbara, Ali Kocabaş, Rana Ahmed, Althea Aquart-Stewart, Michael Studnicka, Tobias Welte, Wan C. Tan, Richard N. Van Zyl-Smit, Parvaiz Koul, Vanessa Garcia-Larsen, Cosetta Minelli, A. Sonia Buist, Peter Burney

Research output: Contribution to journal › Article › peer-review

15 Citations (Scopus)

Abstract

The Burden of Obstructive Lung Disease (BOLD) study was established to assess the prevalence of chronic airflow obstruction, a key characteristic of chronic obstructive pulmonary disease, and its risk factors in adults (≥40 years) from general populations across the world.

The baseline study was conducted between 2003 and 2016, in 41 sites across Africa, Asia, Europe, North America, the Caribbean and Oceania, and collected high-quality pre- and post-bronchodilator spirometry from 28 828 participants.

The follow-up study was conducted between 2019 and 2021, in 18 sites across Africa, Asia, Europe and the Caribbean. At baseline, there were in these sites 12 502 participants with high-quality spirometry. A total of 6452 were followed up, with 5936 completing the study core questionnaire. Of these, 4044 also provided high-quality pre- and post-bronchodilator spirometry.

On both occasions, the core questionnaire covered information on respiratory symptoms, doctor diagnoses, health care use, medication use and ealth status, as well as potential risk factors. Information on occupation, environmental exposures and diet was also collected.

Original language	English
Pages (from-to)	e364-e373
Journal	International Journal of Epidemiology
Volume	52
Issue number	6
DOIs	https://doi.org/10.1093/ije/dyad146
Publication status	Published - 20 Oct 2023

Keywords

Chronic obstructive pulmonary disease
global health
non-communicable respiratory disease

Access to Document

10.1093/ije/dyad146Licence: CC BY

Dyad146Final published version, 1.7 MBLicence: CC BY

Cite this

Amaral, A. F. S., Potts, J., Knox-Brown, B., Bagkeris, E., Harrabi, I., Cherkaski, H. H., Agarwal, D., Juvekar, S., Anand, M. P., Gislason, T., Nafees, A. A., Mortimer, K., Janson, C., Loh, L. C., Paraguas, S. N., Denguezli, M., Al Ghobain, M., Mannino, D., Njoroge, M., ... Burney, P. (2023). Cohort Profile: Burden of Obstructive Lung Disease (BOLD) study. International Journal of Epidemiology, 52(6), e364-e373. https://doi.org/10.1093/ije/dyad146

@article{c3e5c2ec2c514775a5338245c47cdb73,

title = "Cohort Profile: Burden of Obstructive Lung Disease (BOLD) study",

abstract = "The Burden of Obstructive Lung Disease (BOLD) study was established to assess the prevalence of chronic airflow obstruction, a key characteristic of chronic obstructive pulmonary disease, and its risk factors in adults (≥40 years) from general populations across the world.The baseline study was conducted between 2003 and 2016, in 41 sites across Africa, Asia, Europe, North America, the Caribbean and Oceania, and collected high-quality pre- and post-bronchodilator spirometry from 28 828 participants.The follow-up study was conducted between 2019 and 2021, in 18 sites across Africa, Asia, Europe and the Caribbean. At baseline, there were in these sites 12 502 participants with high-quality spirometry. A total of 6452 were followed up, with 5936 completing the study core questionnaire. Of these, 4044 also provided high-quality pre- and post-bronchodilator spirometry.On both occasions, the core questionnaire covered information on respiratory symptoms, doctor diagnoses, health care use, medication use and ealth status, as well as potential risk factors. Information on occupation, environmental exposures and diet was also collected.",

keywords = "Chronic obstructive pulmonary disease, global health, non-communicable respiratory disease",

author = "Amaral, \{Andre F.S.\} and James Potts and Ben Knox-Brown and Emmanouil Bagkeris and Imed Harrabi and Cherkaski, \{Hamid Hacene\} and Dhiraj Agarwal and Sanjay Juvekar and Anand, \{Mahesh Padukudru\} and Thorarinn Gislason and Nafees, \{Asaad Ahmed\} and Kevin Mortimer and Christer Janson and Loh, \{Li Cher\} and Paraguas, \{Stefanni Nonna\} and Meriam Denguezli and \{Al Ghobain\}, Mohammed and David Mannino and Martin Njoroge and Graham Devereux and Terence Seemungal and Cristina Barbara and Ali Kocaba{\c s} and Rana Ahmed and Althea Aquart-Stewart and Michael Studnicka and Tobias Welte and Tan, \{Wan C.\} and \{Van Zyl-Smit\}, \{Richard N.\} and Parvaiz Koul and Vanessa Garcia-Larsen and Cosetta Minelli and Buist, \{A. Sonia\} and Peter Burney",

year = "2023",

month = oct,

day = "20",

doi = "10.1093/ije/dyad146",

language = "English",

volume = "52",

pages = "e364--e373",

journal = "International Journal of Epidemiology",

issn = "0300-5771",

publisher = "Oxford University Press",

number = "6",

}

Amaral, AFS, Potts, J, Knox-Brown, B, Bagkeris, E, Harrabi, I, Cherkaski, HH, Agarwal, D, Juvekar, S, Anand, MP, Gislason, T, Nafees, AA, Mortimer, K, Janson, C, Loh, LC, Paraguas, SN, Denguezli, M, Al Ghobain, M, Mannino, D, Njoroge, M, Devereux, G, Seemungal, T, Barbara, C, Kocabaş, A, Ahmed, R, Aquart-Stewart, A, Studnicka, M, Welte, T, Tan, WC, Van Zyl-Smit, RN, Koul, P, Garcia-Larsen, V, Minelli, C, Buist, AS & Burney, P 2023, 'Cohort Profile: Burden of Obstructive Lung Disease (BOLD) study', International Journal of Epidemiology, vol. 52, no. 6, pp. e364-e373. https://doi.org/10.1093/ije/dyad146

TY - JOUR

T1 - Cohort Profile: Burden of Obstructive Lung Disease (BOLD) study

AU - Amaral, Andre F.S.

AU - Potts, James

AU - Knox-Brown, Ben

AU - Bagkeris, Emmanouil

AU - Harrabi, Imed

AU - Cherkaski, Hamid Hacene

AU - Agarwal, Dhiraj

AU - Juvekar, Sanjay

AU - Anand, Mahesh Padukudru

AU - Gislason, Thorarinn

AU - Nafees, Asaad Ahmed

AU - Mortimer, Kevin

AU - Janson, Christer

AU - Loh, Li Cher

AU - Paraguas, Stefanni Nonna

AU - Denguezli, Meriam

AU - Al Ghobain, Mohammed

AU - Mannino, David

AU - Njoroge, Martin

AU - Devereux, Graham

AU - Seemungal, Terence

AU - Barbara, Cristina

AU - Kocabaş, Ali

AU - Ahmed, Rana

AU - Aquart-Stewart, Althea

AU - Studnicka, Michael

AU - Welte, Tobias

AU - Tan, Wan C.

AU - Van Zyl-Smit, Richard N.

AU - Koul, Parvaiz

AU - Garcia-Larsen, Vanessa

AU - Minelli, Cosetta

AU - Buist, A. Sonia

AU - Burney, Peter

PY - 2023/10/20

Y1 - 2023/10/20

N2 - The Burden of Obstructive Lung Disease (BOLD) study was established to assess the prevalence of chronic airflow obstruction, a key characteristic of chronic obstructive pulmonary disease, and its risk factors in adults (≥40 years) from general populations across the world.The baseline study was conducted between 2003 and 2016, in 41 sites across Africa, Asia, Europe, North America, the Caribbean and Oceania, and collected high-quality pre- and post-bronchodilator spirometry from 28 828 participants.The follow-up study was conducted between 2019 and 2021, in 18 sites across Africa, Asia, Europe and the Caribbean. At baseline, there were in these sites 12 502 participants with high-quality spirometry. A total of 6452 were followed up, with 5936 completing the study core questionnaire. Of these, 4044 also provided high-quality pre- and post-bronchodilator spirometry.On both occasions, the core questionnaire covered information on respiratory symptoms, doctor diagnoses, health care use, medication use and ealth status, as well as potential risk factors. Information on occupation, environmental exposures and diet was also collected.

AB - The Burden of Obstructive Lung Disease (BOLD) study was established to assess the prevalence of chronic airflow obstruction, a key characteristic of chronic obstructive pulmonary disease, and its risk factors in adults (≥40 years) from general populations across the world.The baseline study was conducted between 2003 and 2016, in 41 sites across Africa, Asia, Europe, North America, the Caribbean and Oceania, and collected high-quality pre- and post-bronchodilator spirometry from 28 828 participants.The follow-up study was conducted between 2019 and 2021, in 18 sites across Africa, Asia, Europe and the Caribbean. At baseline, there were in these sites 12 502 participants with high-quality spirometry. A total of 6452 were followed up, with 5936 completing the study core questionnaire. Of these, 4044 also provided high-quality pre- and post-bronchodilator spirometry.On both occasions, the core questionnaire covered information on respiratory symptoms, doctor diagnoses, health care use, medication use and ealth status, as well as potential risk factors. Information on occupation, environmental exposures and diet was also collected.

KW - Chronic obstructive pulmonary disease

KW - global health

KW - non-communicable respiratory disease

U2 - 10.1093/ije/dyad146

DO - 10.1093/ije/dyad146

M3 - Article

SN - 0300-5771

VL - 52

SP - e364-e373

JO - International Journal of Epidemiology

JF - International Journal of Epidemiology

IS - 6

ER -

Cohort Profile: Burden of Obstructive Lung Disease (BOLD) study

Abstract

Keywords

Access to Document

Fingerprint

Cite this